Naz Elina*
Androgenic alopecia, commonly known as male or female pattern baldness, is a prevalent condition that affects millions of individuals worldwide. While surgical hair transplant procedures have long been the primary treatment option, the emergence of Spark Wave® Therapy (SWT)-assisted treatment has provided a novel alternative. This literature explores the concept of SWT-assisted treatment for androgenic alopecia, its methodology, limitations, and implications. The approach involves using a dermaroller with microneedles to create controlled microdamages in the scalp, stimulating the body’s repair mechanisms. The integration of SWT further enhances the therapeutic effects by inducing angiogenesis and regeneration. However, limitations include the need for clinical trials to establish efficacy, standardization of treatment protocols, and individual variability in response. Despite these limitations, SWT-assisted treatment shows promise as a safe and effective alternative to surgical hair transplants. Ongoing research and validation are crucial to refine the technique and provide evidencebased guidelines for practitioners. SWT-assisted treatment has the potential to revolutionize hair restoration by offering a non-surgical solution for androgenic alopecia